Turmeric Compound May Improve Cognitive Function
the Psychiatry Advisor take:
Curcumin, a key compound in the spice turmeric, may help to improve cognitive function, according to researchers.
Andrew Scholey, PhD, of the Swinburne University of Technology, in Melbourne, Australia, and colleagues enrolled 60 healthy adults, aged 60 to 85 years, who were randomly given either a 400 mg capsule containing curcumin or a placebo.
Just an hour after treatment, those in the curcumin group demonstrated better performance on tasks related to attention and working memory compared to those on placebo, the researchers reported in the Journal of Psychopharmacology.
Results also showed that when the supplement was taken for 30 days, those in the curcumin group showed improvements in calmness, contentment, and less fatigue compared with placebo.
Cucumin may help alleviate fatigue, because the compound influences mitochondrial function, the protein kinase, and glucose uptake and regulation, according to the researchers. A previous study found that curcumin may also be effective as a depression treatment.
Turmeric Compound May Work As Depression Treatment
Curcumin possesses many properties which may prevent or ameliorate pathological processes underlying age-related cognitive decline, dementia or mood disorders. However, these benefits in preclinical studies have not been established in humans.
This randomized, double-blind, placebo-controlled trial examined the acute (one and three hours after a single dose), chronic (four weeks) and acute-on-chronic (one and three hour after single dose following chronic treatment) effects of solid lipid curcumin formulation (400 mg as Longvida®) on cognitive function, mood and blood biomarkers in 60 healthy adults aged 60 to 85 years.
Psychiatry Advisor Articles
- Early Detection Markers of Alzheimer's Disease Possibly Identified
- Transcranial Direct Current Stimulation Inferior to Escitalopram
- Illicit Cannabis Use Among Adults Up Due to Medical Marijuana Laws
- Memory Training Opportunities Exist for Patients With Schizophrenia
- APA: Medical Discrimination Based on Size Psychologically, Physically Harms Patients
- Criteria For Identification of Smartphone Addiction
- Bipolar Disorder: Childhood Trauma Modulates Impact on Amygdala, Hippocampus
- Psychiatric Evaluations: Questions on Suicide Need to Be Rephrased
- Subsequent Suicide Attempts May Be Reduced by Emergency Department Interventions
- Elevated Levels of Childhood Adversity in Patients with Fibromyalgia and Chronic Widespread Pain
- Neonatal Drug Withdrawal Risk Increased With Opioid Plus Psychotropic Drugs
- Improvisational Music Therapy Not Beneficial in Children With Autism
- Negative Symptoms In Schizophrenia Reduced By Novel Therapy
- Prescription Opioid Misuse Remains a Persistent Problem
- Revised Treatment Guidelines for Pediatric Acute Onset Neuropsychiatric Syndrome